Company Filing History:
Years Active: 2017-2024
Title: David Schroeckenfuchs: Innovator in Pharmaceutical Manufacturing
Introduction
David Schroeckenfuchs is a notable inventor based in Ernstbrunn, Austria. With a keen focus on pharmaceutical innovations, he has contributed significantly to the field, holding three patents that highlight his expertise and creativity. His work primarily revolves around the manufacturing of semi-plastic pharmaceutical dosage units, showcasing his dedication to improving pharmaceutical production processes.
Latest Patents
David's latest patents include a groundbreaking process for the manufacture of semi-plastic pharmaceutical unit doses. This process employs a rotary moulding machine, enabling the production of semi-plastic pharmaceutical dosage units that are essential for effective drug delivery. The innovation lies in enhancing the efficiency and reliability of pharmaceutical manufacturing, ultimately benefiting the healthcare sector.
Career Highlights
Throughout his career, David Schroeckenfuchs has showcased his ingenuity and commitment to advancing pharmaceutical technologies. His role at Intervet Inc. has allowed him to pioneer essential processes and contribute to the company’s mission in the pharmaceutical industry. His focus on efficiency and innovation positions him as a key player in enhancing drug formulation methodologies.
Collaborations
David collaborates closely with esteemed colleagues, including Dominique Kluger and Carsten Schmidt. These partnerships foster a creative environment that promotes shared knowledge and innovative solutions. Working together, they push the boundaries of pharmaceutical manufacturing, striving to develop more effective and practical methods for drug formulation.
Conclusion
David Schroeckenfuchs stands out as a remarkable inventor in the pharmaceutical industry. His latest patents and collaborative efforts reflect his strong commitment to innovation and improvement in drug manufacturing processes. As he continues to explore new avenues in pharmaceutical technology, David’s contributions are sure to make a significant impact on the industry.